Details of the Drug Formulations

General Information of Drug (ID: DMHZCPO)

Drug Name
Ibrutinib Drug Info
Synonyms PCI-32765; Ibrutinib (BTK inhibitor)
Indication
Disease Entry ICD 11 Status REF
Mantle cell lymphoma 2A85.5 Approved [1]
Small lymphocytic lymphoma 2A82.0 Approved [2]
Waldenstrom macroglobulinemia 2A85.4 Approved [2]
B-cell non-hodgkin lymphoma 2B33.5 Phase 3 [3]
Diffuse large B-cell lymphoma 2A81 Phase 3 [3]
Follicular lymphoma 2A80 Phase 3 [3]
Non-hodgkin lymphoma 2B33.5 Phase 3 [3]
Pancreatic cancer 2C10 Phase 3 [3]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 [4]
Solid tumour/cancer 2A00-2F9Z Phase 2 [3]
Cross-matching ID
PubChem CID
24821094
ChEBI ID
CHEBI:76612
CAS Number
936563-96-1
TTD ID
D09KTS
VARIDT ID
DR01270
INTEDE ID
DR0843
ACDINA ID
D01146

Full List of Drug Formulations Containing This Drug

Ibrutinib 280mg tablet
Company Formulation ID FDA Description
Pharmacyclics F23772 Colloidal Silicon Dioxide; Croscarmellose Sodium; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Povidone; Sodium Lauryl Sulfate; Ferrosoferric Oxide; Polyvinyl Alcohol; Polyethylene Glycol; Red Iron Oxide; Talc; Titanium Dioxide
------------------------------------------------------------------------------------
Ibrutinib 140mg tablet
Company Formulation ID FDA Description
Pharmacyclics F23773 Colloidal Silicon Dioxide; Croscarmellose Sodium; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Povidone; Sodium Lauryl Sulfate; Ferrosoferric Oxide; Polyvinyl Alcohol; Polyethylene Glycol; Talc; Titanium Dioxide; Yellow Iron Oxide
------------------------------------------------------------------------------------
Ibrutinib 560mg tablet
Company Formulation ID FDA Description
Pharmacyclics F23775 Colloidal Silicon Dioxide; Croscarmellose Sodium; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Povidone; Sodium Lauryl Sulfate; Polyvinyl Alcohol; Polyethylene Glycol; Red Iron Oxide; Talc; Titanium Dioxide; Yellow Iron Oxide
------------------------------------------------------------------------------------
Ibrutinib 420mg tablet
Company Formulation ID FDA Description
Pharmacyclics F23774 Colloidal Silicon Dioxide; Croscarmellose Sodium; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Povidone; Sodium Lauryl Sulfate; Ferrosoferric Oxide; Polyvinyl Alcohol; Talc; Titanium Dioxide; Yellow Iron Oxide
------------------------------------------------------------------------------------
Ibrutinib 70mg capsule
Company Formulation ID FDA Description
Pharmacyclics F23777 Croscarmellose Sodium; Magnesium Stearate; Microcrystalline Cellulose; Sodium Lauryl Sulfate; Gelatin; Titanium Dioxide; Black Ink; Yellow Iron Oxide
------------------------------------------------------------------------------------
Ibrutinib 140mg capsule
Company Formulation ID FDA Description
Pharmacyclics F23776 Croscarmellose Sodium; Magnesium Stearate; Microcrystalline Cellulose; Sodium Lauryl Sulfate; Gelatin; Titanium Dioxide; Black Ink
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6912).
2 Ibrutinib FDA Label
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization